Skip to main content

Table 1 Characteristics of urban and rural outlets selected in Ghana, Kenya, Nigeria, Tanzania, and Uganda

From: Artemisinin-based combination therapy availability and use in the private sector of five AMFm phase 1 countries

 

Ghana

Kenya

Nigeria

Tanzania

Uganda

 

Urban (n = 100)

Rural (n = 20)

Urban (n = 77)

Rural (n = 42)

Urban (n = 82)

Rural (n = 38)

Urban (n = 96)

Rural (n = 24)

Urban (n = 79)

Rural (n = 40)

Outlet type, n (%)

Pharmacy

77 (77.0)

-

76 (98.6)

40 (95.0)

8 (9.7)

2 (5.3)

81 (84.4)

2 (8.3)

31 (39.3)

2 (5.0)

Drug shop

13 (13.0)

20 (100.0)

-

-

11 (13.4)

2 (5.3)

3 (3.1)

8 (33.3)

5 (6.3)

18 (45.0)

Private clinic/Health facility

10 (10.0)

-

-

2 (5.0)

3 (3.7)

1 (2.6)

8 (8.3)

4 (16.7)

40 (50.6)

20 (50.0)

Patent medicine store

-

-

-

-

54 (65.9)

32 (84.2)

-

-

-

-

Other

-

-

1 (1.4)

-

6 (7.3)

1 (2.6)

4 (4.2)

10 (41.7)

3 (3.8)

-

Outlet size, Median (Range)

Total tablets sold in the past week per outlet for the top 3 ACT products

50 (0–1860)

14 (0–380)

420 (0–13725)

411 (0–16800)

414 (0–532800)

408 (0–7070)

350 (0–212800)

360 (4–1296)

480 (0–74800)

234 (0–5040)

Licensed (%)

100.0

100.0

97.2

85.0

59.8

39.5

100.0

100.0

100.0

100.0